June 3, 2014

In an effort to spotlight the importance of early detection of memory problems, the Alzheimer's Foundation of America on Monday announced it is collaborating with Rite Aid to offer free, confidential memory screenings at all Rite Aid stores on June 4, from 10 a.m. to 2 p.m.

March 26, 2014

Early-stage Alzheimer’s disease, or AD, increasingly is the target of drug development efforts, but there are very few tools that measure the cognitive function of patients with the condition before the onset of dementia. Experts have concluded that it is best to treat patients prior to changes in cognition, before the symptoms of neurodegeneration appear. As a result, scientists have turned to biomarkers to provide some indication of whether AD is likely to develop.

January 2, 2014

Among patients with mild to moderate Alzheimer disease, a daily dosage of 2,000 IUs of vitamin E, compared to placebo, was effective in slowing functional decline and in reducing caregiver time in assisting patients, according to a study that appeared in the Jan. 1 issue of JAMA.

July 8, 2013

More than half of the estimated 5.4 million Americans with Alzheimer's disease and other forms of dementia are at risk of wandering and becoming lost, according to the National Institute on Aging, a figure that has prompted the federal government to develop a series of training videos for police.

April 4, 2013

The annual cost of treating dementia in the United States ranges from $157 billion to $215 billion, according to a new study by the RAND Corp.

December 7, 2012

Being mildly vitamin B-12 deficient could be an indication that some older adults are at a greater risk for accelerated cognitive decline, according to an observational study from researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University released Wednesday.

April 6, 2012

Sam's Club is offering free screenings for brain health at all of its stores that operate pharmacies this month, the retailer said Friday.

December 23, 2011

Drug maker Bristol-Myers Squibb and the Gladstone Institutes will collaborate to find new ways to treat Alzheimer's disease, the two said Thursday.

November 11, 2011

Watson Pharmaceuticals is challenging Swiss drug maker Novartis' patent on a drug used to treat dementia, Watson said.

September 21, 2011

A study published in the Sept. 20 issue of Neurology, the medical journal of the American Academy of Neurology, found a link between diabetes and the development of dementia.

February 9, 2011

The National Advertising Division of the Council of Better Business Bureaus on Wednesday announced that Pharmavite is able to support advertising claims for the company’s NatureMade GreatMind dietary supplement, pursuant to NAD’s ongoing monitoring of advertising for dietary supplements.

January 5, 2011

BALTIMORE — If the government paid for drug cost incentives for Medicare patients with congestive heart failure, the program could recoup those costs and more by spending less on expensive hospitalizations for patients. 


That finding was one of several to emerge from research conducted by pharmacy students at the University of Maryland School of Pharmacy. The four students presented their findings on elderly drug adherence at the annual meeting of the Gerontology Society of America in New Orleans.

November 7, 2010

According to a study published in the November edition of Alzheimer’s & Dementia: The Journal...

November 4, 2010

A daily dose of beet juice may increase blood flow to the brain and keep...

November 3, 2010

Nearly 100 drugs are in development for treating Alzheimer’s disease, according to a new report...

October 29, 2010

SILVER SPRING , Md. (Oct. 29) The Food and Drug Administration has approved a new drug for treating schizophrenia, the agency said Thursday.

The FDA announced the approval of Latuda (lurasidone hydrochloride), made by Fort Lee, N.J.-based Sunovion Pharmaceuticals. The drug is approved to treat adults with the disease, a mental illness that causes hallucinations, delusions, paranoia and disordered thinking and behavior.

September 9, 2010

A small study conducted by Canadian researchers found factors that may link Type 2 diabetes...

July 19, 2010

More than 300 medications for treating mental disorders are in development, according to a new...

July 6, 2010

Sandoz has launched a version of a drug for treating dementia, the generics arm of...

July 5, 2010

Generic drug maker Caraco Pharmaceutical Labs has begun shipping a drug for treating dementia, Caraco...

June 30, 2010

Watson Pharmaceuticals has launched a generic version of a drug used to treat dementia under...

June 22, 2010

The Food and Drug Administration has approved a drug made by Forest Labs and Germany-based...

March 7, 2010

Diabetic adults with depression are twice as likely to develop dementia, according to a new...